Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T32880 | Target Info | |||
Target Name | HIF-prolyl hydroxylase 2 (HPH-2) | ||||
Synonyms | SM-20; Prolyl hydroxylase domain-containing protein 2; PHD2; Hypoxia-inducible factor prolyl hydroxylase 2; HPH-2; HIF-PH2; Egl nine homolog 1; C1orf12 | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | EGLN1 | ||||
Biochemical Class | Paired donor oxygen oxidoreductase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 2-(carboxymethylamino)-2-oxoacetic acid | Ligand Info | |||
Canonical SMILES | C(C(=O)O)NC(=O)C(=O)O | ||||
InChI | 1S/C4H5NO5/c6-2(7)1-5-3(8)4(9)10/h1H2,(H,5,8)(H,6,7)(H,9,10) | ||||
InChIKey | BIMZLRFONYSTPT-UHFFFAOYSA-N | ||||
PubChem Compound ID | 3080614 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5L9R HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with N-oxalylglycine (NOG) | ||||||
Method | X-ray diffraction | Resolution | 1.81 Å | Mutation | Yes | [1] |
PDB Sequence |
TKPLPALKLA
194 LEYIVPAMNK204 HGICVVDDFL214 GKETGQQIGD224 EVRALHDTGK234 FTDGQLVSQK 244 SDSSKDIRGD254 KITWIEGKEP264 GCETIGLLMS274 SMDDLIRHCN284 GKLGSYKING 294 RTKAMVACYP304 GNGTGYVRHV314 DNPNGDGRCV324 TCIYYLNKDW334 DAKVSGGILR 344 IFPEGKAQFA354 DIEPKFDRLL364 FFWSDRRNPH374 EVQPAYATRY384 AITVWYFDAD 394 ERAAAKVKYL404
|
|||||
|
ILE207
3.960
VAL209
2.340
ASP211
4.865
ARG252
3.918
ASP254
4.467
MET299
2.470
TYR303
2.750
TYR310
2.859
HIS313
2.722
ASP315
3.366
ILE327
2.505
TYR329
1.766
LEU343
2.301
ALA354
2.586
|
|||||
PDB ID: 5L9V HIF prolyl hydroxylase 2 (PHD2-R281C/P317C) cross-linked to HIF-1alpha NODD-L397C/D412C and N-oxalylglycine (NOG) (complex-1) | ||||||
Method | X-ray diffraction | Resolution | 1.83 Å | Mutation | Yes | [1] |
PDB Sequence |
PALKLALEYI
198 VPAMNKHGIC208 VVDDFLGKET218 GQQIGDEVRA228 LHDTGKFTDG238 QLVSQKSDSS 248 KDIRGDKITW258 IEGKEPGCET268 IGLLMSSMDD278 LICHCNGKLG288 SYKINGRTKA 298 MVACYPGNGT308 GYVRHVDNCN318 GDGRCVTCIY328 YLNKDWDAKV338 SGGILRIFPE 348 GKAQFADIEP358 KFDRLLFFWS368 DRRNPHEVQP378 AYATRYAITV388 WYFDADERAA 398 AKVKY
|
|||||
|
ARG252
3.904
ASP254
4.489
MET299
2.579
TYR303
3.310
TYR310
2.812
HIS313
2.655
ASP315
3.533
ILE327
2.619
TYR329
1.870
LEU343
2.258
|
|||||
PDB ID: 5LAS HIF prolyl hydroxylase 2 (PHD2-R281C/P317C/R396T) cross-linked to HIF-1alpha NODD-L397C/D412C and N-oxalylglycine (NOG) (complex-3) | ||||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | Yes | [1] |
PDB Sequence |
PALKLALEYI
198 VPAMNKHGIC208 VVDDFLGKET218 GQQIGDEVRA228 LHDTGKFTDG238 QLVSQKSDSS 248 KDIRGDKITW258 IEGKEPGCET268 IGLLMSSMDD278 LICHCNGKLG288 SYKINGRTKA 298 MVACYPGNGT308 GYVRHVDNCN318 GDGRCVTCIY328 YLNKDWDAKV338 SGGILRIFPE 348 GKAQFADIEP358 KFDRLLFFWS368 DRRNPHEVQP378 AYATRYAITV388 WYFDADETAA 398 AKVKY
|
|||||
|
ARG252
3.840
ASP254
4.628
MET299
2.584
TYR303
3.397
TYR310
2.829
HIS313
2.395
ASP315
3.427
ILE327
2.661
TYR329
1.924
LEU343
2.188
|
|||||
PDB ID: 5LA9 HIF prolyl hydroxylase 2 (PHD2-R281C/V314C) cross-linked to HIF-1alpha NODD-L397C/D412C and N-oxalylglycine (NOG) (complex-2) | ||||||
Method | X-ray diffraction | Resolution | 2.81 Å | Mutation | Yes | [1] |
PDB Sequence |
LPALKLALEY
197 IVPAMNKHGI207 CVVDDFLGKE217 TGQQIGDEVR227 ALHDTGKFTD237 GQLVIRGDKI 256 TWIEGKEPGC266 ETIGLLMSSM276 DDLICHCNGK286 LGSYKINGRT296 KAMVACYPGN 306 GTGYVRHCDN316 PNGDGRCVTC326 IYYLNKDWDA336 KVSGGILRIF346 PEGKAQFADI 356 EPKFDRLLFF366 WSDRRNPHEV376 QPAYATRYAI386 TVWYFDADER396 AAAKV |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .OGA or .OGA2 or .OGA3 or :3OGA;style chemicals stick;color identity;select .A:252 or .A:254 or .A:299 or .A:303 or .A:310 or .A:313 or .A:315 or .A:327 or .A:329 or .A:343 or .A:366 or .A:374 or .A:375 or .A:376 or .A:383 or .A:385 or .A:387 or .A:389; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 3HQR PHD2:Mn:NOG:HIF1-alpha substrate complex | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | Yes | [2] |
PDB Sequence |
QTKPLPALKL
193 ALEYIVPCMN203 KHGICVVDDF213 LGKETGQQIG223 DEVRALHDTG233 KFTDGQLVSQ 243 KSDSSKDIRG253 DKITWIEGKE263 PGCETIGLLM273 SSMDDLIRHC283 NGKLGSYKIN 293 GRTKAMVACY303 PGNGTGYVRH313 VDNPNGDGRC323 VTCIYYLNKD333 WDAKVSGGIL 343 RIFPEGKAQF353 ADIEPKFDRL363 LFFWSDRRNP373 HEVQPAYATR383 YAITVWYFDA 393 DERAAAKVKY403 LTGEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .OGA or .OGA2 or .OGA3 or :3OGA;style chemicals stick;color identity;select .A:252 or .A:254 or .A:299 or .A:303 or .A:310 or .A:313 or .A:315 or .A:327 or .A:329 or .A:343 or .A:366 or .A:374 or .A:376 or .A:383 or .A:385 or .A:387 or .A:389; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 7Q5V HIF PROLYL HYDROXYLASE 2 (PHD2/EGLN1) IN COMPLEX WITH N-OXALYLGLYCINE (NOG) AND HIF-2 ALPHA CODD (523-542) | ||||||
Method | X-ray diffraction | Resolution | 1.17 Å | Mutation | No | [3] |
PDB Sequence |
TKPLPALKLA
194 LEYIVPCMNK204 HGICVVDDFL214 GKETGQQIGD224 EVRALHDTGK234 FTDGQLVSQK 244 SDSSKDIRGD254 KITWIEGKEP264 GCETIGLLMS274 SMDDLIRHCN284 GKLGSYKING 294 RTKAMVACYP304 GNGTGYVRHV314 DNPNGDGRCV324 TCIYYLNKDW334 DAKVSGGILR 344 IFPEGKAQFA354 DIEPKFDRLL364 FFWSDRRNPH374 EVQPAYATRY384 AITVWYFDAD 394 ERARAKVKYL404 TGE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .OGA or .OGA2 or .OGA3 or :3OGA;style chemicals stick;color identity;select .A:252 or .A:254 or .A:299 or .A:303 or .A:310 or .A:313 or .A:315 or .A:327 or .A:329 or .A:343 or .A:358 or .A:366 or .A:374 or .A:375 or .A:376 or .A:383 or .A:385 or .A:387 or .A:389; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 6YW4 HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with N-oxalylglycine (NOG) and a RaPID-derived silent allosteric cyclic peptide 3C (14-mer) | ||||||
Method | X-ray diffraction | Resolution | 1.53 Å | Mutation | No | [4] |
PDB Sequence |
KPLPALKLAL
195 EYIVPAMNKH205 GICVVDDFLG215 KETGQQIGDE225 VRALHDTGKF235 TDGQDIRGDK 255 ITWIEGKEPG265 CETIGLLMSS275 MDDLIRHCNG285 KLGSYKINGR295 TKAMVACYPG 305 NGTGYVRHVD315 NPNGDGRCVT325 CIYYLNKDWD335 AKVSGGILRI345 FPEGKAQFAD 355 IEPKFDRLLF365 FWSDRRNPHE375 VQPAYATRYA385 ITVWYFDADE395 RAAAKVKYLT 405
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .OGA or .OGA2 or .OGA3 or :3OGA;style chemicals stick;color identity;select .A:252 or .A:254 or .A:299 or .A:303 or .A:310 or .A:313 or .A:315 or .A:327 or .A:329 or .A:343 or .A:358 or .A:366 or .A:374 or .A:376 or .A:383 or .A:385 or .A:387 or .A:389; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 6YW3 HIF PROLYL HYDROXYLASE 2 (PHD2/ EGLN1) in complex with N-Oxalyl Glycine (NOG), HIF-1ALPHA CODD (556-574) and a RaPID-derived cyclic peptide 3C (14-mer) | ||||||
Method | X-ray diffraction | Resolution | 2.28 Å | Mutation | No | [4] |
PDB Sequence |
TKPLPALKLA
194 LEYIVPCMNK204 HGICVVDDFL214 GKETGQQIGD224 EVRALHDTGK234 FTDGQLVSQK 244 SDSSKDIRGD254 KITWIEGKEP264 GCETIGLLMS274 SMDDLIRHCN284 GKLGSYKING 294 RTKAMVACYP304 GNGTGYVRHV314 DNPNGDGRCV324 TCIYYLNKDW334 DAKVSGGILR 344 IFPEGKAQFA354 DIEPKFDRLL364 FFWSDRRNPH374 EVQPAYATRY384 AITVWYFDAD 394 ERARAKVKYL404 TGE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .OGA or .OGA2 or .OGA3 or :3OGA;style chemicals stick;color identity;select .A:252 or .A:254 or .A:299 or .A:301 or .A:303 or .A:310 or .A:313 or .A:315 or .A:327 or .A:329 or .A:343 or .A:358 or .A:366 or .A:374 or .A:376 or .A:383 or .A:385 or .A:387 or .A:389; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. Nat Commun. 2016 Aug 26;7:12673. | ||||
REF 2 | Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure. 2009 Jul 15;17(7):981-9. | ||||
REF 3 | HIF PROLYL HYDROXYLASE 2 (PHD2/EGLN1) IN COMPLEX WITH N-OXALYLGLYCINE (NOG) AND HIF-2 ALPHA CODD (523-542) | ||||
REF 4 | Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2. Sci Rep. 2020 Dec 15;10(1):21964. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.